MD, Prof Aron Goldhirsch, PhD, Prof Richard D Gelber, MD, Prof Martine J Piccart-Gebhart, MD, Evandro de Azambuja, MSci, Marion Procter, MD, Prof Thomas M Suter, MD, Prof Christian Jackisch, MD, Prof David Cameron, MD, Harald A Weber, PhD, Dominik Heinzmann, MD, Lissandra Dal Lago, MA, Eleanor McFadden, PhD, Prof Mitch Dowsett, MD, Prof Michael Untch, MD, Luca Gianni, MD, Prof Richard Bell, MD, Prof Claus-Henning Köhne, MD, Anita Vindevoghel, MD, Michael Andersson, MD, A Murray Brunt, MD, Douglas Otero-Reyes, MD, Santai Song, MD, Prof Ian Smith, PhD †, Brian Leyland-Jones, MD †, Prof Jose Baselga, "2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial", LANCET, 2013